Algernon Pharmaceuticals Inc. - Warrants
Algernon Pharmaceuticals Inc. - Warrants
CSE Index:
Currency:
Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough.
Algernon Pharmaceuticals Inc. - Warrants (AGN.WT)
SEDAR Information
Company Info
Address
Suite 900 - 700 West Pender Street
Vancouver, BC V6C 1G8
CanadaPhone
604-398-4175Ext
701Email
chris@algernonpharmaceuticals.comWebsite
https://algernonpharmaceuticals.comListing date
Monday, November 4, 2019Transfer Agent
AST Trust Company (Canada)Capitalization
Issued & Outstanding:
24401300Reserved for Issuance:
0News Releases
Bulletins
21/04/2023
2023-0422 - Expiry - Algernon Pharmaceuticals Inc. - Rights (AGN.RT)
le 21 avril/April 2023
Algernon Pharmaceuticals Inc. Rights listed on March 28, 2023 will expire on April 27, 2023.
Settlement Terms: All trades April 25 and 26 will be for cash next day settlement. Trades on April 27 will be for cash same day.
The rights will be halted at noon and delisted at market close April 27, 2023.
___________________________
CSE Filings
